Isiqingatha sabathengi Siyishiya iMimiselo kwi-Pharmacy ngenxa yeendleko

A BAMBA isiKhululo sasimahla 2 | eTurboNews | eTN
Ibhalwe ngu Linda Hohnholz

Nokuba kukho izixhobo zokubeka elubala amaxabiso, izigulane ezininzi zisashiywe ebumnyameni malunga neendleko ezichazwe ngugqirha, kunye nesiqingatha sabathengi abalahla amayeza afunekayo kwikhemesti, ngokophando lwakutsha nje lwabathengi oluxhaswe nguvulindlela wezempilo uDrFirst.

"Lo ngummandla onobungozi kwimpilo yoluntu," kusho uColin Banas, MD, MHA, igosa eliyintloko lezonyango likaDktFirst. "Kwezinye izigulana, ngakumbi ezo zineemeko zempilo ezingapheliyo ezifana nesifo seswekile, isifo sentliziyo, kunye noxinzelelo lwegazi oluphezulu, ukulahlwa ngugqirha kunokukhokelela kwiingxaki zempilo ezinzulu kunye nokubuyiselwa esibhedlele."

Ukungabambeleli okunxulumene neendleko kunokuba ngunobangela ophambili wokufa e-US ngo-2030, ukodlula isifo seswekile, umkhuhlane, inyumoniya, kunye nesifo sezintso, ngokophononongo olwenziwa yi-West Health Policy Centre kunye ne-Xcenda. Ukuqonda ngcono umba, uGqrFirst uvavanye abathengi abangama-200 baseMelika malunga namava abo ngemigqaliselo kunye nokucaca kwexabiso.

Uvavanyo lufumanise ukuba:

• Phantse isiqingatha sabathengi (43%) bathi oogqirha babo khange baxoxe ngeendleko zamayeza kagqirha kwiinyanga ezili-12 ezidlulileyo.

• Isiqingatha (49.5%) sithi bawushiyile umyalelo kagqirha ekhemesti kule minyaka imbalwa idlulileyo kuba ububiza kakhulu.

• Phantse ikota (24%) bathi baluyekile unyango olumiselweyo kuba bengasakwazi ukulufikelela

• Umsebenzisi omnye kwabali-10 (11%) unika ingxelo ethatha ngaphantsi kwesixa esimiselweyo ukonga imali

“Umothuko wezinto ezincamathelayo usaqhubeka nokuba ngumqobo ekubambeleleni kumayeza, kwaye akukho sizathu sako,” utshilo uBanas. “Izigulana akufuneki zikhe zothuswe ziindleko zamayeza kwikhawuntara yekhemesti. Izixhobo zokubonisa amaxabiso ezifumanekayo namhlanje zivumela abagqirha ukuba babone ulwazi lwekopi yezigulane zabo kwangethuba ukuze baxoxe ngeendleko zamayeza kunye nezinye iindlela ezinokusetyenziswa.”

Ukongeza, izigulana zithi ziyayixabisa imibhalo esabelana ngeendleko kunye nolwazi lokonga ukunceda ukuphepha izinto ezimangalisayo. Abathathi-nxaxheba balinganisa ukufumana ulwazi malunga neendleko zabo ezingaphandle kwepokotho njengeyona nto ibaluleke kakhulu (41%), ilandelwa ngcaciso ngokubanzi malunga neyeza (23%), amakhuphoni edijithali anciphisa iindleko (18.5%), kunye neendleko ze-prescription ukuba zithe bathe gqolo. musa ukusebenzisa i-inshurensi (18%).

"Ukuthotyelwa kweyeza kuyimfanelo ekwabelwana ngayo phakathi kwababoneleli bezempilo kunye nezigulane, ngoko ke ababoneleli kufuneka baqonde iindleko eziphuma ngaphandle kunye neendleko zonyango olulolunye ukuze babe neengxoxo ezinentsingiselo kunye nezigulane kwaye benze izigqibo ezichazwe ngokubhaliweyo," kusho uDkt. Iibhanana. "Kwaye izigulana kufuneka zibe nokufikelela kwi-copay information yemigqaliselo yazo nokuba ngaba umboneleli wazo uyayixoxa nabo."

UDkt. Banas uqaphele ukuba uDktFirst wenza inzuzo kunye nolwazi lweendleko ezifumanekayo kubaboneleli kunye nezigulane. I-myBenefitCheck inika oogqirha ulwazi malunga nokuhamba komsebenzi kwiindleko zamayeza ngexesha le-ofisi okanye utyelelo lwezempilo, ngokusekwe kwi-inshurensi yezempilo yezigulana, ukunceda ekukhetheni amayeza abaguli abanokuwafumana kunye nokwandisa amathuba okuba izigulane zibambelele kunyango lwazo lwamachiza. UGqrFirst wayengowokuqala kwishishini ukunika ukucaca kwexabiso kubaboneleli bezempilo kwi-elektroniki echaza ukuhamba komsebenzi kwaye uye waqhubekeka ngaphezulu kwe-185 yezigidi zentengiselwano ukuza kuthi ga ngoku. I-RxInform inceda ekunciphiseni ukulahlwa komyalelo ngokubonelela izigulane ngolwazi lwe-copay, iividiyo zemfundo, kunye namakhuphoni ngeetekisi ezikhuselekileyo ezithunyelwa ngokuzenzekelayo xa imimiselo ye-elektroniki isendleleni eya ekhemesti, efumene ngaphezu kwe-90% yamazinga okwaneliseka kwesigulane.

Phakathi kwabathengi be-200 abathatha inxaxheba kwi-survey ye-intanethi, i-52.5% yayingamadoda kunye ne-47.5% yabasetyhini. Iqela leminyaka elikhulu limelwe yi-25-34 (28.5%), ilandelwa yi-35-44 (27.5%), kunye nangaphezulu kweminyaka engama-54 (17%).

INTO ONOKUYITHATHA KWELI NQAKU:

  • “Medication adherence is a shared responsibility between healthcare providers and patients, so providers need to understand out-of-pocket costs as well as the costs of alternative therapies so they can have meaningful discussions with patients and make informed prescribing decisions,”.
  • Nokuba kukho izixhobo zokubeka elubala amaxabiso, izigulane ezininzi zisashiywe ebumnyameni malunga neendleko ezichazwe ngugqirha, kunye nesiqingatha sabathengi abalahla amayeza afunekayo kwikhemesti, ngokophando lwakutsha nje lwabathengi oluxhaswe nguvulindlela wezempilo uDrFirst.
  • DrFirst was the first in the industry to provide price transparency to healthcare providers in the electronic prescribing workflow and has processed more than 185 million transactions to date.

<

Malunga nombhali

Linda Hohnholz

Umhleli oyintloko we eTurboNews esekwe kwi-eTN HQ.

Bhlisa
Yaziswe ngawo
guest
0 izimvo
Inline feedbacks
Jonga zonke izimvo
0
Ndingazithanda iingcinga zakho, nceda uphawule.x
Yabelana ku...